Dr Claire Behm
Dr Claire Behm is a Senior Medical Advisor and Director of the Signal Investigation Unit in the Pharmacovigilance and Special Access Branch of the Therapeutic Goods Administration (TGA). Following several years working in hospital-based clinical roles, Dr Behm joined the TGA in 2011 and in 2016 was appointed as a Senior Medical Advisor. In her current role, Dr Behm leads a team of medical officers and pharmacists responsible for detecting, investigating and coordinating the regulatory response to safety signals that arise with medicines marketed in Australia. Dr Behm is also an Advanced Trainee with the Australasian Faculty of Public Health Medicine.